Reply to: Safe outpatient treatment of CNS lymphoma achieved by using glucarpidase after high-dose methotrexate Correspondence

  

Authors:	Schaff, L. R.; Grommes, C.
Title:	Reply to: Safe outpatient treatment of CNS lymphoma achieved by using glucarpidase after high-dose methotrexate
Keywords:	clinical article; methotrexate; rituximab; drug megadose; neurotoxicity; outcome assessment; letter; progression free survival; vincristine; hematopoietic stem cell transplantation; procarbazine; cerebrospinal fluid; long term care; outpatient; hematopoietic stem cell; outpatient care; therapy; carboxypeptidase g2; central nervous system lymphoma; human; article
Journal Title:	JCO Oncology Practice
Volume:	21
Issue:	5
ISSN:	2688-1527
Publisher:	American Society of Clinical Oncology
Date Published:	2025-05-01
Start Page:	729
End Page:	730
Language:	English
DOI:	10.1200/op-24-00988
PUBMED:	39746175
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85217041449&doi=10.1200%2fOP-24-00988&partnerID=40&md5=496b3ebdd7a95ca25c1bcdc09880dccc
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/226504